LifeSci Venture Partners is a venture capital firm in New York that focuses on biotech and health sectors. Founded 2017 in New York, United States by Paul Yook, it invests in early stage ventures. Its portfolio companies include Cala Health, Biolinq, Attune Pharmaceuticals, Akero Therapeutics, Orasis Pharmaceuticals, and Allakos. As of March 2020, LifeSci Venture Partners has made seven investments. Their most recent investment was on May 21, 2019, when Cala Health raised $50M. LifeSci Venture Partners has had two exits, the most notable of which include Allakos and Akero Therapeutics.
Timeline
Funded Companies
Caribou Biosciences is a Berkeley California based private company founded in 2011 by Jennifer Doudna and Rachel Haurwitz based on CRISPR technology.
Iridia is a DNA researching and developing company.
Akero Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on reversing the NASH epidemic by restoring the body's metabolism to a balanced state.
Biolinq, Inc. is a company founded by Joshua Windmiller.
Orasis Pharma is a Tel Aviv-based company in the pharmaceutical industry.
People
Julie Mauser
Executive
Paul Yook
Founder
Ryan Cinalli Ph.D
Executive
Further reading
Documentaries, videos and podcasts
Companies
Akero Therapeutics
Attune Pharmaceuticals
Biolinq
Cala Health
Orasis Pharmaceuticals
News
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 3
Edita Rexha
Economist - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Stefan Steinbauer
A civil engineer who stumbled into coding and fell in love with marketing. Do I need to say more?